INTRODUCTION
Campylobacters normally reside in the intestine of animals such as poultry, pigs, cattle, etc., without causing any symptoms (Man, 2011) . Human infection is mostly attributed to the consumption of contaminated meats such as chicken, and to contact with companion animals (Carbonero et al., 2012; Hald et al., 2004; Steinhauserova et al., 2000; Young et al., 2007) . Campylobacters are considered to be a leading cause of zoonotic disease in humans worldwide and are also associated with septicaemia and severe complications caused by post-infection, such as pancreatitis, reactive arthritis, haemolytic-uraemic syndrome and Guillain-Barré syndrome (Man, 2011; SivadonTardy et al., 2013; Yuki & Hartung, 2012) .
Butzler medium, modified charcoal cefoperazone deoxycholate agar (mCCDA) and Bolton broth. In fact, C. fetus, C. hyointestinalis, Campylobacter lari and C. upsaliensis, in addition to C. jejuni and C. coli, have successfully been isolated from patients with diarrhoea by using non-selective media, for example in the Cape Town protocol (Lastovica & le Roux, 2000; Prouzet-Mauléon et al., 2006; Vandenberg et al., 2004) . Furthermore, a hydrogen-enriched atmosphere (generally 3-7 % hydrogen) is required for the growth of some Campylobacter species, such as Campylobacter concisus and some C. hyointestinalis, which is not routinely used in most laboratories. Therefore, information on the species present in a clinical sample, as might be gained by PCR, may aid selection of appropriate culture methods for its isolation.
Cytolethal distending toxin (CDT) is known to be a possible virulence factor in many pathogenic Gram-negative bacteria, including Campylobacter spp. (Yamasaki et al., 2006) . The cdt gene cluster, consisting of cdtA, cdtB and cdtC, was shown to be ubiquitously present in C. jejuni, C. coli and C. fetus in a species-specific manner . Furthermore, cdt genes are also known to be present in C. lari (Matsuda et al., 2008) , C. upsaliensis , C. hyointestinalis (W. Samosornsuk and others, unpublished observation) and C. helveticus (S. Somroop and others, unpublished observation) indicating that cdt may be one of the best target genes to identify Campylobacter species that are important for human and animal diseases.
In this study, we have successfully developed a PCRrestriction fragment length polymorphism (PCR-RFLP) assay using a common primer set designed from the conserved regions of the cdtB gene for the detection and differentiation of these seven Campylobacter species and evaluated it with 277 strains, including 35, 19, 20, 24, 13, 2, 22 and 4 of C. jejuni, C. coli, C. fetus, C. hyointestinalis, C. lari, C. helveticus, C. upsaliensis and three other species of Campylobacter, respectively, and 17 other bacterial species belonging to 10 different genera associated with humans and animals. Furthermore, 21 clinical specimens from diarrhoeal patients and 10 bovine bile samples were also analysed by this PCR-RFLP assay.
METHODS
Bacterial strains, media and growth conditions. Details of bacterial strains used in this study are summarized in Table 1 . Campylobacter strains isolated from clinical samples were identified as Campylobacter spp. by culture methods, Gram staining, morphology under microscopy and biochemical tests (catalase and oxidase activities). If necessary, biochemical tests using API Campy (bioMérieux), 16S rRNA gene sequencing, detection of the hipO gene by PCR and the cdt gene-based multiplex PCR assay were used for the identification at species level (Asakura et al., 2008; Shiramaru et al., 2012) . Campylobacter spp., Arcobacter spp. and Helicobacter spp. except C. concisus, Campylobacter curvus and Campylobacter hominis, were grown on blood agar [blood base agar no. 2 (Oxoid) supplemented with 5 % (v/v) defibrinated horse blood (Nippon Bio-Supp.)] under microaerobic conditions (5 % O 2 , 7.5 % CO 2 , 7.5 % H 2 , 80 % N 2 ) at 37 uC for 2 days or more. C. concisus, C. curvus and C. hominis strains were grown on blood agar containing 6 % formate and fumarate under anaerobic conditions (80 % N 2 , 10% CO 2 , 10% H 2 ). Aggregatibacter actinomycetemcomitans was grown on trypticase soy agar (TSA; Becton Dickinson) supplemented with 0.6 % yeast extract (Becton Dickinson) at 37 uC for 2 days under 10 % CO 2 in 90 % air. Shigella spp., Vibrio cholerae, Providencia alcalifaciens and Escherichia coli were grown in Luria-Bertani broth (LB; Becton Dickinson) at 37 uC overnight. Escherichia albertii and Salmonella enterica were grown in trypticase soy broth (TSB; Becton Dickinson) at 37 uC overnight. Yersinia enterocolitica was grown in TSB at 30 uC for 2 days. Vibrio parahaemolyticus was grown in alkaline peptone water (Nissui) containing 3 % sodium chloride at 37 uC overnight. Haemophilus ducreyi was grown in brain-heart infusion broth (Becton Dickinson) supplemented with 10 % (v/v) fetal bovine serum (Life Technologies), 10 g haemoglobin l 21 (Becton Dickinson) and 1 % (v/v) IsoVitalex (Becton Dickinson) at 37 uC for 5 days under microaerobic conditions. DNA preparation. Template DNA for PCR assay was prepared by the boiling method as previously described (Hoshino et al., 1998) , with slight modifications. Briefly, bacteria were grown on appropriate agar plates and suspended in 1 ml TE buffer (10 mM Tris/HCl, 1 mM EDTA pH 8.0), or 50 ml mid-exponential phase bacterial culture was added to 450 ml TE buffer. Alternatively, 180 ml clinical and animal samples were mixed with 20 ml 106 TE buffer. The suspension was boiled for 10 min, kept on ice for 5 min, and centrifuged at 12 800 g for 5 min. Supernatant was collected and stored at 220 uC until use. Supernatant (1 ml) was used as DNA template for PCR assay.
PCR method. C. jejuni strain 81-176 (Pickett et al., 1996) , C. coli strain Co1-243 (Asakura et al., 2008) , C. fetus strain ATCC 27374 T (Asakura et al., 2008) , C. hyointestinalis strain Ch022 (W. Samosornsuk and others, unpublished observation), C. lari strain 298 (Matsuda et al., 2008) , C. helveticus strain ATCC 51209 T (Stanley et al., 1992) and C. upsaliensis strain ATCC 43954
T (Standstedt & Ursing, 1991) were used as positive controls (reference strains) and E. coli strain C600 was used as a negative control. PCR was performed with a common primer set, C-CdtBcom1 and C-CdtBcom2, as described by , using a TaKaRa PCR Thermal Cycler (Takara Bio) or Applied Biosystems GeneAmp PCR 9700 (Life Technologies). Oligonucleotide primers were from GeneDesign (Osaka). PCR mixture contained 0.5 mM each of C-CdtBcom1 and C-CdtBcom2 primers, 1 ml template DNA, 0.2 mM each of dATP, dCTP, dGTP and dTTP, 16 Ex Taq DNA polymerase buffer, and 1.0 U Ex Taq DNA polymerase (Takara Bio) in a 40 ml reaction volume. The samples were subjected to an initial denaturation at 94 uC for 3 min, followed by 30 amplification cycles, each consisting of 94 uC for 30 s, 50 uC for 30 s and 72 uC for 30 s. A final primer extension at 72 uC for 3 min was included. PCR products were analysed by 2 % agarose gel electrophoresis and bands were visualized with UV light after staining with ethidium bromide. Images were captured on a Bio-Rad Gel Doc system (Bio-Rad).
DNA sequence analysis. The DNA sequence of each of the PCR products was determined using an ABI PRISM 3100-Avant Genetic Analyzer (Life Technologies). Sequencing was performed by the chain-termination method with the BigDye terminator v1.1 cycle sequencing kit (Life Technologies). The sequences obtained in this study were analysed using the DNA Lasergene software package (DNASTAR). Sequence homology search was performed using BLASTN (National Center for Biotechnology Information).
PCR-RFLP assay. PCR products (1 to 5 ml) were digested with 5 U DdeI (New England Biolabs) and/or 7.5 U EcoRI (Takara Bio) in a final volume of 10 ml at 37 uC overnight. The resulting fragments were analysed by 4 % agarose gel electrophoresis as described above.
Detection limit of the cdtB gene-specific PCR. Campylobacter cells freshly grown on blood agar were suspended in sterile PBS and each bacterial suspension was 10-fold serially diluted using sterile PBS. Each dilution was spread on blood agar to determine viable bacterial cell count and also used to prepare template DNA by the boiling method as described above. For PCR assay only 1 ml of the prepared DNA was used as template.
Analysis of clinical samples. Rectal swabs were collected from 21 children with diarrhoea (from 3 months to 13 years and 9 months of age) who visited the paediatric department of Mizushima Central Hospitals, Okayama, Japan. The specimen was suspended in 500 ml sterile saline. DNA template was prepared by the boiling method as described above and 1 ml template DNA was used for PCR-RFLP assay.
One loop of stool suspension (approx. 10 ml) was inoculated onto mCCDA (Oxoid) agar. A 100 ml portion of the suspension was also applied onto a mixed cellulose ester-type membrane filter (0.45 mm pore size, 47 mm diameter; Advantec Toyo) placed on a blood agar plate, and the filter was removed after 30 min of incubation at room temperature (Shiramaru et al., 2012) . Both of the agar plates were incubated under microaerobic conditions at 37 uC for 2-3 days. Suspected colonies were subcultured on blood agar plates, followed by Gram staining, examination of morphology by microscopy, and the cdt gene-based multiplex PCR (Asakura et al., 2008) .
Analysis of animal samples. Bile was randomly collected from ten healthy cattle. Preston broth (CM0067, Oxoid) supplemented with antibiotics (SR0117, Oxoid), growth supplement (SR0232, Oxoid) and 5 % (v/v) defibrinated horse blood was prepared according to the manufacturer's recommendation. For enrichment culture, 1 ml bile was mixed with 4 ml 1.256 Preston broth and incubated at 37 uC under microaerobic conditions for 24 h. A 1 ml aliquot of bile with or without enrichment culture was centrifuged at 200 g for 10 min. The supernatant was collected and centrifuged at 12 800 g for 10 min. The pellet was washed once with sterile PBS and suspended in 1 ml sterile PBS. The suspension was used for the preparation of DNA template and isolation of campylobacters. DNA template was prepared by the boiling method as described above and 1 ml template DNA was used for PCR-RFLP assay.
Bile samples without enrichment were inoculated onto mCCDA and blood agars using the filtration method, and bile samples with enrichment were inoculated onto mCCDA as described above. Culture plates were incubated at 37 uC under microaerobic conditions for 3 days. Suspected colonies were subcultured and species were identified as described above.
Spike experiment. A stool specimen was obtained from a healthy person. A 2 g portion of this stool specimen was suspended in 8 ml sterile PBS. The suspension was enriched with Preston broth and the stool samples with or without enrichment culture were inoculated onto mCCDA agar plates or filter membranes on blood agar plates as described above. Culture plates were incubated at 37 uC under microaerobic conditions for 5 days.
Portions (0.2 g) of the healthy stool specimen were spiked with 10 3 to 10 8 c.f.u. of each reference strain, such as C. jejuni strain 81-176, C. coli strain Co1-243 and C. hyointestinalis strain Ch022. The spiked sample was suspended in 800 ml sterile PBS and the suspension was centrifuged at 200 g for 10 min. The supernatant was collected and centrifuged at 12 800 g for 10 min. The pellet was suspended in 1 ml sterile PBS, and the suspension was centrifuged again under the same conditions. The pellet was suspended in 500 ml sterile PBS. The sample was boiled for 10 min, kept on ice for 5 min, and centrifuged at 12 800 g for 5 min. Supernatant was collected and treated with phenol/chloroform/isoamyl alcohol (25 : 24 : 1, by vol.). DNA was precipitated with ethanol and suspended in 200 ml TE. The suspension was treated with RNase A (50 mg ml 21 ) at 37 uC for 30 min, and phenol/chloroform/ isoamyl alcohol, and the DNA was precipitated with ethanol. Finally, the purified DNA was suspended in 30 ml TE and 1 ml was used as DNA template for PCR-RFLP assay. species. A specific PCR product was obtained from each of the strains of these seven species except for three strains of C. hyointestinalis (Table 1 ). The sensitivity was determined to be 88 % (21/24) in the case of C. hyointestinalis and 100 % for all other target species. Interestingly, crude cell lysates prepared from three PCR-negative C. hyointestinalis strains showed cytotoxicity to HeLa cells (data not shown), indicating that cdt-like genes might be present in these PCR-negative C. hyointestinalis strains.
Specificity of the assay, evaluated with other Campylobacter species, such as C. concisus, C. curvus and C. hominis, and 10 different genera including 17 different species given in Table 1 , was found to be 100 %. Irrespective of cdt gene cluster possession, cdtB gene-specific PCR products were not obtained from other Campylobacter and bacterial species tested (Table 1 ). The detection limit was evaluated with each reference strain and determined to be 10 to 10 2 c.f.u. per tube for C. jejuni, C. coli, C. fetus, C. lari, C. helveticus and C. upsaliensis, and 10 3 to 10 4 c.f.u. per tube for C. hyointestinalis (data not shown).
Development and evaluation of a PCR-RFLP assay
DNA sequences of the cdtB gene of reference strains (Table 1) were compared to see whether or not appropriate restriction sites are available for the RFLP analysis to differentiate the seven target species. It was found that the combination of DdeI and EcoRI restriction enzymes would generate speciesspecific RFLP patterns. To assess the utility of the PCR-RFLP assay for the species identification, restriction digestion with both DdeI and EcoRI or single digestion was carried out with PCR products obtained using genomic DNAs of 132 Campylobacter strains (Table 1 ). Restriction digestion revealed that the RFLP patterns of reference strains could clearly differentiate all the seven target species of Campylobacter (Fig. 1a, lanes 2, 3, 6-10) . Furthermore, RFLP patterns of all C. jejuni, C. fetus, C. hyointestinalis, C. lari and C. helveticus strains, 17 out of 19 C. coli strains and 16 out of 22 C. upsaliensis strains were the same as each of the reference strains used (Table 1) . However, the RFLP patterns of two C. coli and six C. upsaliensis strains were found to be different from their corresponding reference strains (Fig. 1a, lanes 4 , 5 and 11, 12, respectively). To examine whether the PCR products resembled the cdtB gene of C. coli or C. upsaliensis, nucleotide sequence analysis was done for all these eight PCR products. This indicated nearly identical sequence to that of the cdtB gene of C. coli or C. upsaliensis (Table S1 ). However, some mutations resulted in loss or gain of DdeI or EcoRI restriction site (data not shown). Therefore, the PCR-RFLP patterns obtained from C. coli strains , and C. upsaliensis strains ATCC 43954 T , 40-1, 99-1 were designated Cc-I, Cc-II, Cc-III, and Cu-I, Cu-II, Cu-III, respectively (Fig. 1a , lanes 3-5 and 10-12, respectively). RFLP patterns of C. coli Co1-194 and C. helveticus ATCC 51209 T strains (Cc-II and Che) were found to be very similar (Fig.  1b, lanes 6-8) . However, single digestion with either DdeI or EcoRI could clearly differentiate these two species (Fig. 1b,  lanes 2-5) .
Differentiation of Campylobacter species by PCR product sequencing
Since PCR-RFLP assay did not differentiate very clearly between C. coli and C. helveticus, we tested whether sequencing of the PCR products could directly differentiate the seven Campylobacter species. Among 132 Campylobacter strains examined in this study, the sequences of the cdtB genes of 39 strains have already been reported Matsuda et al., 2008; Parkhill et al., 2000; Pickett et al., 1996 ; W. Samosornsuk and others, unpublished observation; S. Somroop and others, unpublished observation). Therefore, the PCR products (each about 720 bp in size) of the remaining 93 strains were sequenced to confirm the species by comparison with the cdtB gene of each reference strain. Nucleotide sequences of all PCR products were matched with that of either C. jejuni (92.9-100 % identity), C. coli (99.2-100 %), C. fetus (99.3-100 %), C. hyointestinalis (97.9-100 %), C. lari (99.2-100 %), C. helveticus (100 %) or C. upsaliensis (96.8-100 %) (Table S1 ). All results obtained by the PCR-RFLP assay were completely identical to those obtained by sequencing. The results suggest that sequencing of PCR products can also be utilized for differentiation of the seven species of Campylobacter.
Application of PCR-RFLP assay to human and animal samples
To evaluate whether PCR-RFLP assay is applicable to human samples, we used the PCR-RFLP assay developed in dSeven strains are cdt-gene negative. §Two strains are cdt-gene negative. ||Four strains are Cdt-I positive, one strain is Cdt-II positive, two strains are Cdt-III positive, four strains are Cdt-IV positive and three strains are Cdt-V positive.
One strain is Cdt-I positive, one strain is Cdt-II positive, three strains are Cdt-III positive, one strain is Cdt-IV positive and two strains are Cdt-V positive. # Thirteen strains are O1 and ten strains are non-O1/non-O139. **These strains were provided by Junko Isobe, Toyama Institute of Health, Toyama, Japan. Detection and differentiation of seven campylobacters this study with DNA templates prepared from clinical specimens of diarrhoeal patients. We tested 7 and 14 Campylobacter culture-positive and -negative stool samples, respectively ( Table 2 ). The PCR-RFLP assay detected campylobacters from all seven stool samples that were culture-positive (C. jejuni, C. coli and C. fetus were isolated from five, one and one samples, respectively), indicating that the sensitivity was 100 %. No PCR bands were obtained from the 14 stool samples that were culture-negative, indicating that the specificity of the PCR-RFLP assay was also 100 %.
We further evaluated the PCR-RFLP assay with ten bovine bile samples. The PCR-RFLP assay detected C. jejuni directly from three bile samples and from two bile samples that were enriched (Table 2) . Among ten bile samples, C. jejuni was isolated from six by the mCCDA culture method. Thus, the sensitivity was determined to be 83 % (five PCR-RFLP-positives versus six culture-positives). Since no PCR products were obtained from the other four samples, which were also Campylobacter culture-negative, the specificity of the PCR-RFLP assay was thus 100 %.
Detection limit of campylobacters in stool specimens
To examine the detection limit of campylobacters in stool specimens, the PCR-RFLP assay was evaluated by the 'spike experiment' (see Methods). A stool specimen, in which campylobacters were undetectable by culture methods, was spiked with reference strains of C. jejuni, C. coli or C. hyointestinalis. The DNA templates prepared from the spiked samples were used for the PCR-RFLP assay and the detection limit was determined to be 3610 6 c.f.u. g 21 for C. jejuni, 2610 6 c.f.u. g 21 for C. coli and 2610 7 c.f.u. g 21 for C. hyointestinalis.
DISCUSSION
The campylobacters most frequently isolated from human diarrhoeal stool specimens are C. jejuni and C. coli (Bullman et al., 2011; Inglis et al., 2011) . Culture methods currently in use for isolation of Campylobacter species are suitable for cephem-resistant species such as C. jejuni and C. coli (Gharst et al., 2013; Noormohamed & Fakhr, 2012) . Campylobacter species susceptible to cephem antibiotics, such as C. fetus, C. hyointestinalis, C. helveticus and C. upsaliensis, might be underestimated. Indeed, non-C. jejuni/C. coli strains such as C. fetus, C. upsaliensis, C. hyointestinalis, have been successfully isolated from patients with diarrhoea by means of non-selective media (Lastovica & le Roux, 2000; ProuzetMauléon et al., 2006; Vandenberg et al., 2004) . If we knew which Campylobacter species is present in human clinical specimens or animal samples such as meat and stool specimens before isolation, we could choose an appropriate selective medium and culture condition. This could increase the isolation rate of non-C. jejuni/C. coli strains, resulting in a better understanding of the real picture of Campylobacter infections. For this reason, in the present study, we attempted to develop and evaluate a PCR-RFLP assay targeting the cdtB genes of seven Campylobacter species for detection and differentiation at the species level. have reported that cdt genes are ubiquitously present in C. jejuni, C. coli and C. fetus in a lanes 2, 4, 6, 8) or C. helveticus (ATCC 51209 T , lanes 3, 5, 7) were digested with DdeI (lanes 2, 3) or EcoRI (lanes 4, 5), or both (lanes 6-8). In lanes 1 and 9, a 100 bp DNA ladder was used as molecular mass marker.
species-specific manner, and developed a cdt gene-based multiplex PCR (Asakura et al., 2008) which successfully identified these three campylobacters at the species level (Kabir et al., 2011; Samosornsuk et al., 2007; Shiramaru et al., 2012) . Recently, the entire nucleotide sequences of the cdt gene cluster of C. upsaliensis , C. lari (Matsuda et al., 2008) , C. hyointestinalis (W. Samosornsuk and others, unpublished observation) and C. helveticus (S. Somroop and others, unpublished observation) have also been determined. Comparison of the nucleotide sequences of these cdtB genes revealed that a common primer set, which can amplify the cdtB gene of C. jejuni, C. coli or C. fetus, could also amplify the cdtB gene present in the other four species of Campylobacter. In this study, we clearly demonstrated that the common primers could amplify the cdtB gene of seven Campylobacter species, and cdtB genes of these four species are also ubiquitously present in a species-specific manner. Furthermore, restriction digestions of the PCR products clearly differentiated species of campylobacters (Fig. 1) . However, RFLP patterns of some C. coli (e.g. and C. helveticus (e.g. ATCC 51209 T ) strains were very similar (Fig. 1b, lanes 6-8) . In this case, single digestion with either DdeI or EcoRI could clearly differentiate these two species (Fig. 1b, lanes 2-5) .
Alternatively, sequencing of the cdt gene-specific amplified PCR product may be used to differentiate Campylobacter species. As shown in this study, the nucleotide sequence of the cdtB gene is very well conserved among Campylobacter species. If an ambiguous result was obtained by RFLP analysis, we could sequence the PCR product to identify the species. However, the major disadvantages are that sequencing reagents are expensive and that an automated DNA sequencer may not be available in an ordinary clinical laboratory involved in routine microbiological examinations.
We further evaluated whether the PCR-RFLP assay is applicable to human and animal samples. DNA templates prepared from Campylobacter culture-positive clinical specimens of diarrhoeal patients and bovine bile followed by PCR-RFLP assay successfully identified C. jejuni, C. coli and C. fetus (Table 2 ). The sensitivity of the assay was 100 % and 83 % for clinical and animal samples, respectively, and the specificity was 100 % in both cases. Furthermore, Campylobacter-like organisms isolated from the digestive tracts of two cattle samples were not identified by the cdtB gene-based multiplex PCR (Asakura et al., 2008) , but the PCR-RFLP assay successfully identified these two bacteria as C. hyointestinalis (data not shown). These data indicate that the PCR-RFLP assay developed in this study is applicable not only to bacterial isolates but also to samples of human and animal origin. However, the number of strains and samples tested in this study is not sufficient and, therefore, further studies are needed to evaluate the distribution of cdt genes in the four Campylobacter species (C. hyointestinalis, C. lari, C. helveticus and C. upsaliensis) and the utility of the PCR-RFLP assay with more human and animal samples.
The PCR-RFLP assay developed in this study was useful in the examination of clinical and animal samples for the presence of seven Campylobacter species, but the detection limit of C. hyointestinalis was lower than that of other campylobacters. The lower detection limit of C. hyointestinalis may be affected by some mutations of primer binding sites because mismatch annealing is found to have the strongest influence on amplification efficiency. One and four mismatches were found in C-CdtBcom1 and CCdtBcom2 primers, respectively, in comparison with the cdtB gene of the C. hyointestinalis reference strain (data not shown). The detection limit may be improved by further modification of common primers.
In conclusion, the cdtB gene-based simple PCR-RFLP assay developed in this study will be useful for the detection and differentiation of seven different Campylobacter species that are involved in human and animal diseases. As mentioned, Detection and differentiation of seven campylobacters some of the species which are really difficult to isolate by applying routinely used selective media in a clinical laboratory were also easily detected and differentiated by the PCR-RFLP assay developed in this study. Thus, cdt genes may serve as good targets to detect and differentiate different important campylobacters involved in human and animal diseases at the species level.
